
Novo Nordisk Introduces Ozempic in India for Type 2 Diabetes, Prices Aligned to Wegovy
Novo Nordisk has launched Ozempic in India, an injectable semaglutide treatment intended for type 2 diabetes. The company is positioning the drug alongside its obesity medication, Wegovy. Pricing will be similar to Wegovy.







